Scott Tarriff
CIK 1469124 · CEO · last filed 2024-03-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
54
Lifetime Open-Market Net
-$24.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | CEO | 1,453,244 | $2.14 | $3.11M | -$24.37M | 37 | 2024-03-01 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 4,186 | $0.87 | $3.6K | $0 | 6 | 2020-01-03 |
| Theriva Biologics, Inc. (SYN) Delisted | Director | 300,000 | $1.02 | $306.0K | $0 | 8 | 2019-12-06 |
| CLINICAL DATA INC (CLDA) Delisted | Director | 0 | — | — | $0 | 3 | 2011-04-14 |
Recent Filings · Page 3 of 6
54 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-25 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | +61,300 | $0 | EDGAR |
| 2019-01-04 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Sell (S) | −31,569 | -$1.25M | EDGAR |
| 2019-01-02 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-07 | Theriva Biologics, Inc. (SYN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-03 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Exer (M) | +124,804 | $504.2K | EDGAR |
| 2018-04-03 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | +55,209 | -$2.59M | EDGAR |
| 2018-01-09 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-03 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-21 | Theriva Biologics, Inc. (SYN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-06 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.